Bone turnover in hyperparathyroidism
- 18 July 2012
- journal article
- review article
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 163 (17-18) , 391-396
Abstract
A narrow serum calcium level which is essential for many metabolic processes is regulated by the calcium-sensing receptor which regulates parathyroid hormone (PTH) release. Primary hyperparathyroidism is supposed to be the third most common endocrine disorder. Besides nephrolithiasis and an increased incidence of cardiovascular symptoms it is associated with bone loss and an increased risk of fracture. Several different classical bone turnover markers have been shown to be increased. However, there are many uncertainties in pathophysiology of PHPT. Hardly any conclusive data exist on the RANK (receptor activator of nuclear factor-kB)/RANKL (receptor activator of nuclear factor-kB ligand)/OPG (osteoprotegerin) system, cathepsin K, sclerostin, FGF-23 (Fibroblast growth factor-23), Klotho, and DKK 1 (Dickkopf 1) in patients suffering from PHPT. Parathormon (PTH) ist ein aus 84 Aminosäuren bestehendes Polypeptid, das einen ganz wesentlichen Regulator der Kalziumhomöostase darstellt. Sezerniert wird das kalziotrope PTH, wenn der „calcium sensing receptor“ eine Abnahme des Serumkalziumspiegels feststellt. Das Krankheitsbild des primären Hyperparathyroidismus (PHPT), der dritthäufigsten endokrinen Erkrankung, ist gekennzeichnet durch Nierensteine, kardiovaskuläre Probleme und eine Abnahme der Knochenmineraldichte sowie das damit einhergehende erhöhte Frakturrisiko. In vielen Studien wurde eine Erhöhung der klassischen Knochenstoffwechselparameter gezeigt. In Bezug auf das RANK (receptor activator of nuclear factor-kB)/RANKL RANKL (receptor activator of nuclear factor-kB ligand)/OPG (osteoprotegerin) System und die Enzyme beziehungsweise Proteine Kathepsin K, Sklerostin, FGF-23 (Fibroblast growth factor-23), Klotho und DKK1 (Dickkopf 1) gibt es allerdings kaum Daten. Die Pathophysiologie des PHPT ist somit noch nicht zur Gänze geklärt.Keywords
This publication has 55 references indexed in Scilit:
- A Potential Role for the Myeloid Lineage in Leptin-regulated Bone MetabolismHormone and Metabolic Research, 2011
- "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density"BMC Medical Genetics, 2011
- Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone FormationCell Metabolism, 2010
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2009
- Control of Bone Mass and Remodeling by PTH Receptor Signaling in OsteocytesPLOS ONE, 2008
- The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2008
- Osteoprotegerin Levels in Primary Hyperparathyroidism: Effect of Parathyroidectomy and Association with Bone MetabolismCalcified Tissue International, 2003
- Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatmentBone, 2000
- Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bonesClinical Endocrinology, 2000
- Evaluation of Changes in Bone Density and Biochemical Parameters after Parathyroidectomy in Primary Hyperparathyroidism.Endocrine Journal, 2000